MBP 3.23% 3.0¢ metabolic pharmaceuticals limited

re: mbp success to be presented june diabetes conf A) No weight...

  1. 46 Posts.
    re: mbp success to be presented june diabetes conf A) No weight rebound with the drug

    B) No weight rebound with placebo

    How can MBP say the drug was 'effective' in preventing weight regain??? In fact, 0.3 kg was put on by the drug group (not statistically significant) compared to the placebo group which lost 0.1 kg in the 12 weeks post trial. As both placebo and drug groups demonstrated equal efficacy in weight loss (i.e. neither showed statistical significant weight loss) then MBP should stop development of the drug and turn instead to trials of placebo pills instead.

    I only hope that the trial results they are planning to publish in the medical literature come to me for peer review (I am a medical scientist who works in obesity and clinical trials) prior to publication as based already on how they are reporting their results and how they have interpreted them will be getting an absolute canning.
 
watchlist Created with Sketch. Add MBP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.